Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | 1 | TNF-a | 20.0 | 81 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | TNF-a | 21.0 | 64 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | TNF-a | 21.5 | 68 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | TNF-a | 20.0 | 65 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | TNF-a | 21.0 | 65 | ||||
N2586 | 1 | TNF-a | 19.0 | 78 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | TNF-a | 16.0 | 66 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | TNF-a | 18.0 | 50 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | TNF-a | 20.5 | 60 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | TNF-a | 21.5 | 58 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | TNF-a | 13.5 | 54 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | TNF-a | 20.0 | 68 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | TNF-a | 21.0 | 77 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 22.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 18.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 22.0 | 80 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 21.0 | 83 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 18.0 | 77 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | TNF-a | 22.0 | 90 | ||||
N2586 | EGF | 100 | ng/mL | 1 | TNF-a | 21.0 | 87 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 19.0 | 77 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 18.0 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 20.0 | 49 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 21.0 | 58 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | TNF-a | 20.0 | 51 |